Fluvoxamine Maleate
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
27241-274 -
Package NDC
27241-274-30 -
Application number
ANDA219055 -
SPL ID
658eeffd-e919-4d41-8814-e55273a471e9 -
SPL set ID
0a6836ab-bd0e-410b-82af-07720e386532 -
UNII
5LGN83G74V -
RxCUI
903873 -
RxCUI
903879
What the source publishes
- Labeler
- Ajanta Pharma USA Inc.
- Active ingredients
- Fluvoxamine Maleate
- Form
- CAPSULE, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Fluvoxamine Maleate",
"splId": "658eeffd-e919-4d41-8814-e55273a471e9",
"labels": [
{
"setId": "0a6836ab-bd0e-410b-82af-07720e386532",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0a6836ab-bd0e-410b-82af-07720e386532",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0a6836ab-bd0e-410b-82af-07720e386532"
}
],
"routes": [
"ORAL"
],
"labeler": "Ajanta Pharma USA Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (27241-274-30)",
"package_ndc": "27241-274-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20241017"
}
],
"productId": "27241-274_658eeffd-e919-4d41-8814-e55273a471e9",
"useDomain": "unknown",
"dosageForm": "CAPSULE, EXTENDED RELEASE",
"productNdc": "27241-274",
"deaSchedule": null,
"genericName": "Fluvoxamine Maleate",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "FLUVOXAMINE MALEATE",
"strength": "100 mg/1"
}
],
"applicationNumber": "ANDA219055",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20241017",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0327241275302",
"0327241274305"
],
"unii": [
"5LGN83G74V"
],
"rxcui": [
"903873",
"903879"
],
"spl_set_id": [
"0a6836ab-bd0e-410b-82af-07720e386532"
],
"manufacturer_name": [
"Ajanta Pharma USA Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:27241-274_658eeffd-e919-4d41-8814-e55273a471e9"